Testing intravitreal toxicity of rapamycin in rabbit eyes

Related authors

• Roberta Pereira de Almeida Manzano
• Gholam A. Peyman
• Palwasha Khan
• Muhamet Kivilcim
• Patricia Chevez-Barrios
• Walter Takahashi

Related articles

• Age-related macular degeneration: a review of current therapies and new treatments
• Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results
• Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
• Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema
• Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
• Unilateral papilledema and peripapillary polypoidal choroidal vasculopathy as the presenting manifestations of intracranial hypertension
• Benzoporphyrin (verteporfin) photodynamic therapy for choroidal neovascularization in age-related macular degeneration
• Fluorofenidone inhibits epithelial-mesenchymal transition in human lens epithelial cell line FHL 124: a promising therapeutic strategy against posterior capsular opacification
• Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?
• Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes

Click here to search